日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke-ACTISAVE: A Prospective, Randomized, Double-Blind Study

Glenzocimab联合静脉溶栓治疗（伴或不伴机械取栓）治疗急性缺血性卒中患者的疗效和安全性——ACTISAVE：一项前瞻性、随机、双盲研究

期刊:Stroke
影响因子:8.9
doi:10.1161/STROKEAHA.125.052935
Köhrmann, Martin; Berrouschot, Jörg; Serena, Joaquín; Bornstein, Natan M; Iversen, Helle K; Kalladka, Dheeraj; Krastev, Georgi; Molina, Carlos A; Peeters, André; Šaňák, Daniel; Sibon, Igor P; Della Schiava, Lucie; Tembl, José I; Masjuan, Jaime; Soda, Hassan; Richard, Sébastien; Eichlova, Zuzana; Czap, Alexandra L; Avenard, Gilles; Binay, Sophie; Bougamra, Sirine; Comenducci, Andrea; Drumez, Elodie; Meilhoc, Adeline; Pletan, Yannick; Sari, Anouar; Toledano, Elie; Grouin, Jean-Marie; Grotta, James C
发表日期：2026
文献求助 收藏

Encorafenib plus binimetinib versus dabrafenib plus trametinib for the first-line treatment of patients with BRAF(V600E)-mutant metastatic non-small cell lung cancer: a matching-adjusted indirect treatment comparison

恩科拉非尼联合比美替尼与达拉非尼联合曲美替尼一线治疗BRAF(V600E)突变转移性非小细胞肺癌患者的疗效比较：一项匹配调整的间接治疗比较研究

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.106051
Planchard, D; Mazières, J; Grouin, J M; Le Reun, C; Luttenauer, H; Boussahoua, M; Macabeo, B
肺癌
肿瘤
肿瘤免疫
BRAF
细胞生物学
发表日期：2026
文献求助 收藏

Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-Injector ZENEO(®) in Healthy Adults

健康成年人使用无针自动注射器 ZENEO(®) 肌内注射咪达唑仑的相对生物利用度研究

期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-024-00627-4
Lacombe, Olivier; Pletan, Yannick; Grouin, Jean-Marie; Brennan, Aislinn; Giré, Olivier
发表日期：2024
文献求助 收藏

Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison

采用匹配调整的间接比较方法，比较比美珠单抗和司库奇尤单抗治疗银屑病关节炎患者 52 周的疗效

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00652-7
Mease, Philip J; Warren, Richard B; Nash, Peter; Grouin, Jean-Marie; Lyris, Nikos; Willems, Damon; Taieb, Vanessa; Eells, Jason; McInnes, Iain B
关节炎
银屑病
发表日期：2024
文献求助 收藏

Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison

采用匹配调整的间接比较法评估比美珠单抗和古塞库单抗治疗银屑病关节炎患者 52 周的疗效

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00659-0
Warren, Richard B; McInnes, Iain B; Nash, Peter; Grouin, Jean-Marie; Lyris, Nikos; Willems, Damon; Taieb, Vanessa; Eells, Jason; Mease, Philip J
关节炎
银屑病
发表日期：2024
文献求助 收藏

Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison

采用匹配调整的间接比较法评估比美珠单抗和乌司奴单抗治疗银屑病关节炎患者 52 周的疗效

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00705-x
Mease, Philip J; Warren, Richard B; Nash, Peter; Grouin, Jean-Marie; Lyris, Nikos; Taieb, Vanessa; Eells, Jason; McInnes, Iain B
关节炎
银屑病
发表日期：2024
文献求助 收藏

Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison

采用匹配调整的间接比较法评估比美珠单抗和利沙珠单抗治疗银屑病关节炎患者 52 周的疗效

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00706-w
Mease, Philip J; Warren, Richard B; Nash, Peter; Grouin, Jean-Marie; Lyris, Nikos; Willems, Damon; Taieb, Vanessa; Eells, Jason; McInnes, Iain B
关节炎
银屑病
发表日期：2024
文献求助 收藏

Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial

评估使用纳吉博肽抑制TREM-1治疗接受呼吸支持的COVID-19患者的疗效和安全性：ESSENTIAL随机、双盲试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102013
François, Bruno; Lambden, Simon; Garaud, Jean-Jacques; Derive, Marc; Grouin, Jean-Marie; Asfar, Pierre; Darreau, Cédric; Mira, Jean-Paul; Quenot, Jean-Pierre; Lemarié, Jérémie; Mercier, Emmanuelle; Lacherade, Jean-Claude; Vinsonneau, Christophe; Fivez, Tom; Helms, Julie; Badie, Julio; Levy, Mitchell; Cuvier, Valérie; Salcedo-Magguilli, Margarita; Laszlo-Pouvreau, Anne-Lise; Laterre, Pierre-François; Gibot, Sébastien
发表日期：2023
文献求助 收藏

Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension period

在日本2型糖尿病患者中，伊美格列明联合胰岛素单药治疗的疗效和安全性（TIMES 3）：一项随机、双盲、安慰剂对照的3期临床试验，并设有36周的开放标签扩展期

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14642
Reilhac, Caroline; Dubourg, Julie; Thang, Carole; Grouin, Jean-Marie; Fouqueray, Pascale; Watada, Hirotaka
代谢
糖尿病
TIM
免疫/内分泌
发表日期：2022
文献求助 收藏

Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week, open-label, multicentre phase 3 trial

在日本2型糖尿病患者中，伊美格列明单药治疗或与现有降糖药物联合治疗的长期安全性和有效性（TIMES 2）：一项为期52周、开放标签、多中心3期临床试验

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14613
Dubourg, Julie; Fouqueray, Pascale; Quinslot, Damien; Grouin, Jean-Marie; Kaku, Kohei
糖尿病
TIM
代谢
发表日期：2022
文献求助 收藏